Cargando…

Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)

BACKGROUND: In the context of prostate cancer (PCa) characterized by the multiple alternative treatment strategies, comparative effectiveness analysis is essential for informed decision-making. We analyzed the comparative effectiveness of PCa treatments through systematic review and meta-analysis wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayadevappa, Ravishankar, Chhatre, Sumedha, Wong, Yu-Ning, Wittink, Marsha N., Cook, Ratna, Morales, Knashawn H., Vapiwala, Neha, Newman, Diane K., Guzzo, Thomas, Wein, Alan J., Malkowicz, Stanley B., Lee, David I., Schwartz, Jerome S., Gallo, Joseph J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419922/ https://www.ncbi.nlm.nih.gov/pubmed/28471976 http://dx.doi.org/10.1097/MD.0000000000006790

Ejemplares similares

Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE)
por: Chhatre, Sumedha, et al.
Publicado: (2015)

Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial
por: Chhatre, Sumedha, et al.
Publicado: (2023)

Continuity of care and advanced prostate cancer
por: Jayadevappa, Ravishankar, et al.
Publicado: (2023)

Association between hospital competition and quality of prostate cancer care
por: Jayadevappa, Ravishankar, et al.
Publicado: (2023)

Patient-Centered Approach to Develop the Patient’s Preferences for Prostate Cancer Care (PreProCare) Tool
por: Jayadevappa, Ravishankar, et al.
Publicado: (2019)

Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer
por: Jayadevappa, Ravishankar, et al.
Publicado: (2019)

Patient-centred outcomes research: perspectives of patient stakeholders
por: Chhatre, Sumedha, et al.
Publicado: (2017)

Sources of Information for Learning and Decision-Making in Men With Localized Prostate Cancer
por: Chhatre, Sumedha, et al.
Publicado: (2020)

Medication adherence in the management of nocturia: challenges and solutions
por: Jayadevappa, Ravishankar, et al.
Publicado: (2015)

Trends in substance use admissions among older adults
por: Chhatre, Sumedha, et al.
Publicado: (2017)

Knowledge and attitude for overactive bladder care among women: development and measurement
por: Chhatre, Sumedha, et al.
Publicado: (2018)

Menopausal status and the risk of lung cancer in women: A PRISMA-compliant meta-analysis
por: Min, Lingfeng, et al.
Publicado: (2017)

The risks of hematological toxicities of nivolumab in cancer patients: A PRISMA-compliant meta-analysis
por: Shi, Zuolin, et al.
Publicado: (2022)

Patient-centered recruitment and retention for a randomized controlled study
por: Chhatre, Sumedha, et al.
Publicado: (2018)

Prognostic value of MSI2 expression in human malignancies: A PRISMA-compliant meta-analysis
por: Wu, Wei, et al.
Publicado: (2022)

The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies
por: Zhu, Linhai, et al.
Publicado: (2016)

The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis
por: Zhang, Jie, et al.
Publicado: (2016)

The prognostic and clinicopathological significance of RBM3 in the survival of patients with tumor: A Prisma-compliant meta-analysis
por: Gao, Guangyu, et al.
Publicado: (2020)

Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review
por: Liu, Wei, et al.
Publicado: (2016)

Can S-1 replace fluorouracil for advanced gastric cancer? A PRISMA-compliant systematic review and meta-analysis
por: Chen, Xiao-Dong, et al.
Publicado: (2016)

Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis
por: Zhang, Zongxin, et al.
Publicado: (2017)

Prognostic value of platelet-to-lymphocyte ratio in neoadjuvant chemotherapy for solid tumors: A PRISMA-compliant meta-analysis
por: Long, Yuming, et al.
Publicado: (2021)

Association between the polymorphisms in XPG gene and gastric cancer susceptibility in Chinese populations: A PRISMA-compliant meta-analysis
por: Xia, Jun, et al.
Publicado: (2017)

Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2018)

No association of TNF-α-308G/A polymorphisms with head and neck cancer risk: A PRISMA-compliant meta-analysis
por: Yuan, Cheng, et al.
Publicado: (2017)

Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis
por: Wang, Qinjing, et al.
Publicado: (2022)

Long-Term Coffee Consumption and Risk of Gastric Cancer: A PRISMA-Compliant Dose–Response Meta-Analysis of Prospective Cohort Studies
por: Zeng, Shao-Bo, et al.
Publicado: (2015)

Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis
por: Qixing, Mao, et al.
Publicado: (2015)

Low expression of nm23-H1 associates with poor survival of nasopharyngeal carcinoma patients: A prisma-compliant meta-analysis
por: Yuan, Cheng, et al.
Publicado: (2017)

Association of cytotoxic T lymphocyte-associated protein 4 gene -1772T/C polymorphism with gastric cancer risk: A prisma-compliant meta-analysis
por: Zhuo, Chenyi, et al.
Publicado: (2020)

Diagnostic value of exosome derived long noncoding RNA in gastric cancer in Chinese population: A PRISMA-compliant systematic review and meta-analysis
por: Zhu, Kangle, et al.
Publicado: (2021)

Association between HIV infection and outcomes of care among medicare enrollees with breast cancer
por: Chhatre, Sumedha, et al.
Publicado: (2019)

Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016
por: Chhatre, Sumedha, et al.
Publicado: (2022)

The Efficacy and Safety of Chemotherapy in Patients With Nonsmall Cell Lung Cancer and Interstitial Lung Disease: A PRISMA-Compliant Bayesian Meta-Analysis and Systematic Review
por: Chen, Yu Jie, et al.
Publicado: (2015)

The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis
por: Zhou, Jian-Guo, et al.
Publicado: (2015)

The Efficacy of Erlotinib Versus Conventional Chemotherapy for Advanced Nonsmall-Cell Lung Cancer: A PRISMA-Compliant Systematic Review With Meta-Regression and Meta-Analysis
por: Ma, Hu, et al.
Publicado: (2016)

Significant association between long non-coding RNA H19 polymorphisms and cancer susceptibility: A PRISMA-compliant meta-analysis and bioinformatics prediction
por: Li, Wei, et al.
Publicado: (2020)

Effect of vitamin B supplementation on cancer incidence, death due to cancer, and total mortality: A PRISMA-compliant cumulative meta-analysis of randomized controlled trials
por: Zhang, Sui-Liang, et al.
Publicado: (2016)

EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients: A PRISMA-compliant systematic review with meta-analysis and meta-regression
por: An, Na, et al.
Publicado: (2016)

Twice-daily vs higher-dose once-daily thoracic radiotherapy for limited-disease small-cell lung cancer: A PRISMA-compliant meta-analysis
por: Yang, Lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tp4ob7q8fld9jjrojfcf4m78g5